Tobin Schilke

Chief Financial Officer


Tobin “Toby” Schilke joined Crinetics as chief financial officer in February 2025. Prior to joining Crinetics, Mr. Schilke served as Chief Financial Officer at Revance Therapeutics between 2018-2025. Mr. Schilke served as Chief Financial Officer at Achaogen 2016-2018. Earlier in his career, he spent more than a decade at Roche/Genentech.

Mr. Schilke holds a bachelor’s degree in chemical engineering from Lafayette College, a master’s degree in chemical engineering from the University of California, Berkeley, and a master’s degree in business administration from Cornell University.